does geha cover glp-1 Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Check Drug Costs tool |

Inflammation markers can guide us to which depressed patients respond best to glutamate blockers," lead author Ebrahim Haroon, MD, said about the study

10.1126/science.1206848

For weight loss, though, its key advantage is metabolic flexibility : it helps the body switch to burning fat stores and may reduce insulin resistance, attacking one root cause of weight gain

It also helps your body become more sensitive to insulin, the hormone responsible for moving sugar out of the blood and into your cells for energy

July 7, 2025 New Study Links Ozempic and Wegovy to Vision Loss Risk A new study published in JAMA Ophthalmology has linked Ozempic and Wegovy to a higher risk of developing neovascular age-related macular degeneration (nAMD), a serious condition that can lead to permanent vision loss